Calliditas Therapeutics AB (publ) (CALT)
USD 40.0
(-0.1%)
USD 40.0
(-0.1%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.51 Billion SEK | 25.18% |
| 2022 | 1.2 Billion SEK | 60.47% |
| 2021 | 753.8 Million SEK | 96.77% |
| 2020 | 383.09 Million SEK | 80.1% |
| 2019 | 212.7 Million SEK | 59.69% |
| 2018 | 133.19 Million SEK | 57.34% |
| 2017 | 84.65 Million SEK | 49.79% |
| 2016 | 56.51 Million SEK | 9.98% |
| 2015 | 51.38 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 485.29 Million SEK | 21.37% |
| 2024 Q2 | 540.53 Million SEK | 11.38% |
| 2023 Q3 | 439.24 Million SEK | 32.97% |
| 2023 Q4 | 399.84 Million SEK | -8.97% |
| 2023 Q2 | 330.34 Million SEK | -9.85% |
| 2023 Q1 | 366.42 Million SEK | -5.72% |
| 2023 FY | 1.51 Billion SEK | 25.18% |
| 2022 Q1 | 257.48 Million SEK | 1.65% |
| 2022 Q2 | 271.5 Million SEK | 5.45% |
| 2022 FY | 1.2 Billion SEK | 60.47% |
| 2022 Q4 | 388.66 Million SEK | 33.12% |
| 2022 Q3 | 291.96 Million SEK | 7.53% |
| 2021 FY | 753.8 Million SEK | 96.77% |
| 2021 Q1 | 150.78 Million SEK | 10.59% |
| 2021 Q4 | 253.31 Million SEK | 33.1% |
| 2021 Q3 | 190.31 Million SEK | 19.39% |
| 2021 Q2 | 159.39 Million SEK | 5.72% |
| 2020 FY | 383.09 Million SEK | 80.1% |
| 2020 Q2 | 66.56 Million SEK | -8.57% |
| 2020 Q1 | 72.8 Million SEK | 12.89% |
| 2020 Q3 | 104.89 Million SEK | 57.58% |
| 2020 Q4 | 136.34 Million SEK | 29.98% |
| 2019 Q4 | 64.48 Million SEK | 22.51% |
| 2019 Q2 | 52.82 Million SEK | 23.65% |
| 2019 Q1 | 42.72 Million SEK | -6.02% |
| 2019 FY | 212.7 Million SEK | 59.69% |
| 2019 Q3 | 52.63 Million SEK | -0.36% |
| 2018 Q4 | 45.46 Million SEK | 45.37% |
| 2018 Q3 | 31.27 Million SEK | 71.76% |
| 2018 Q2 | 18.2 Million SEK | -52.41% |
| 2018 Q1 | 38.25 Million SEK | -5.97% |
| 2018 FY | 133.19 Million SEK | 57.34% |
| 2017 Q4 | 40.68 Million SEK | 132.83% |
| 2017 Q2 | 15.48 Million SEK | 40.68% |
| 2017 Q1 | 11 Million SEK | 0.0% |
| 2017 FY | 84.65 Million SEK | 49.79% |
| 2017 Q3 | 17.47 Million SEK | 12.83% |
| 2016 FY | 56.51 Million SEK | 9.98% |
| 2015 FY | 51.38 Million SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -6704.602% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -7899.514% |
| Vaxxinity, Inc. | 56.05 Million USD | -2601.518% |
| IO Biotech, Inc. | 91.44 Million USD | -1555.926% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -4948.605% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -3121.35% |
| MEI Pharma, Inc. | 34.78 Million USD | -4253.106% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -628.653% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -802.255% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -3898.595% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -558.492% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -794.527% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -38312.216% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -370.611% |
| Agenus Inc. | 78.18 Million USD | -1836.774% |
| AlloVir, Inc. | 180.93 Million USD | -736.9% |
| CRISPR Therapeutics AG | 463.49 Million USD | -226.699% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -798.993% |
| NextCure, Inc. | 67.63 Million USD | -2138.757% |
| Opthea Limited | 191.96 Million USD | -688.794% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -2750.237% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -1062.439% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -6129.697% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -1519.876% |
| Senti Biosciences, Inc. | 94.7 Million USD | -1498.889% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -652.916% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -15137.292% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 15.879% |
| BioLineRx Ltd. | 50.8 Million USD | -2880.646% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -3023.859% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -1687.417% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -3985.441% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -1767.987% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -2044.981% |
| AbCellera Biologics Inc. | 275.23 Million USD | -450.164% |
| ADMA Biologics, Inc. | 66.58 Million USD | -2174.094% |
| Aptorum Group Limited | 10.56 Thousand USD | -14331037.611% |
| AnaptysBio, Inc. | 181.56 Million USD | -733.973% |
| Ardelyx, Inc. | 169.93 Million USD | -791.053% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -239.713% |
| Bicycle Therapeutics plc | 216.92 Million USD | -598.052% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -780.867% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -847.654% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -4528.543% |
| Chimerix, Inc. | 93.38 Million USD | -1521.42% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -10786.176% |
| Dyadic International, Inc. | 9.15 Million USD | -16444.065% |
| Elevation Oncology, Inc. | 45.44 Million USD | -3232.001% |
| ESSA Pharma Inc. | 32.13 Million USD | -4612.215% |
| Fortress Biotech, Inc. | 200.19 Million USD | -656.377% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -496.05% |
| GlycoMimetics, Inc. | 39.28 Million USD | -3754.44% |
| Fortress Biotech, Inc. | 200.19 Million USD | -656.377% |
| ChromaDex Corporation | 56.37 Million USD | -2585.801% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -19585.132% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -1465.741% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -905.891% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -859.502% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -588.818% |
| Incyte Corporation | 1.19 Billion USD | -27.193% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -1042.338% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -18102.044% |
| Jaguar Health, Inc. | 42.01 Million USD | -3504.018% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 53.489% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -17817.738% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -1695.747% |
| ContextLogic Inc. | 387 Million USD | -291.273% |
| Lantern Pharma Inc. | 17.87 Million USD | -8369.988% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -297.962% |
| MiMedx Group, Inc. | 229.72 Million USD | -559.142% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -843.209% |
| Structure Therapeutics Inc. | 102.77 Million USD | -1373.343% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -4524.162% |
| Onconetix, Inc. | 34.9 Million USD | -4237.839% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -11780.025% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -54931.118% |
| PDS Biotechnology Corporation | 43.04 Million USD | -3417.76% |
| Precigen, Inc. | 84.18 Million USD | -1698.776% |
| Pharming Group N.V. | 225.49 Million USD | -571.525% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -1986.691% |
| PureTech Health plc | 144.59 Million USD | -947.206% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -1091.724% |
| Royalty Pharma plc | 862.4 Million USD | -75.582% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -6129.697% |
| Seer, Inc. | 110.49 Million USD | -1270.466% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -562.16% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -4806.925% |
| Acelyrin, Inc. | 422.06 Million USD | -258.767% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -11743563.72% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -1742.216% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -7697.856% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -4820.958% |
| TG Therapeutics, Inc. | 198.47 Million USD | -662.931% |
| Alkermes plc | 996.24 Million USD | -51.993% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -1045.624% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -20195.242% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -2699.978% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -5014.598% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -4342.506% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -735.201% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -517.654% |
| Geron Corporation | 70.44 Million USD | -2049.64% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -8574.045% |
| Summit Therapeutics Inc. | 87.68 Million USD | -1626.875% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -1125.57% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -5038.376% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -22393.176% |
| Innoviva, Inc. | 132.15 Million USD | -1045.806% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -2567.82% |
| Vaxcyte, Inc. | 468.04 Million USD | -223.525% |
| Molecular Templates, Inc. | 63.09 Million USD | -2300.07% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -5001.503% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -275.215% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -2887.055% |
| Novavax, Inc. | 779.12 Million USD | -94.35% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -4374.14% |
| Scopus BioPharma Inc. | 11.71 Million USD | -12825.684% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -483.686% |
| Precision BioSciences, Inc. | 92.46 Million USD | -1537.658% |
| GT Biopharma, Inc. | 13.57 Million USD | -11053.712% |
| ImmuCell Corporation | 9.61 Million USD | -15644.733% |
| Immix Biopharma, Inc. | 16.14 Million USD | -9281.187% |
| Mesoblast Limited | 5.9 Million USD | -25556.184% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -483.16% |
| Aptose Biosciences Inc. | 52.35 Million USD | -2792.177% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -10407.902% |
| Soligenix, Inc. | 7.79 Million USD | -19325.006% |
| Century Therapeutics, Inc. | 56.07 Million USD | -2600.555% |
| Kura Oncology, Inc. | 165.8 Million USD | -813.264% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -1222.389% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -60917.255% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -1305.995% |
| Autolus Therapeutics plc | 196.72 Million USD | -669.714% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -1688.662% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -1200.291% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -7712.145% |
| GRI Bio, Inc. | 11.33 Million USD | -13264.766% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -21361.057% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -1054.199% |
| IGM Biosciences, Inc. | 265.59 Million USD | -470.135% |
| INmune Bio, Inc. | 29.89 Million USD | -4964.985% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -777.539% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -3656.056% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -9376.149% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -9519.305% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -2338.449% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -1308.296% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -449.244% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -402.313% |
| Verastem, Inc. | 92.08 Million USD | -1544.399% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -8340.983% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -715.307% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -1147.233% |
| Histogen Inc. | 14.27 Million USD | -10509.781% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -9335.535% |
| Surrozen, Inc. | 18.55 Million USD | -8062.954% |
| Organovo Holdings, Inc. | 14.91 Million USD | -10052.384% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -29647.697% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -2437.536% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -5804.114% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -19738.322% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -750.04% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -3025.474% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -518.042% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -9754.038% |
| Apollomics, Inc. | 54.14 Million USD | -2696.875% |
| Amarin Corporation plc | 272.35 Million USD | -455.972% |
| Turnstone Biologics Corp. | 78.33 Million USD | -1832.942% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -520.275% |
| Synaptogenix, Inc. | 8.31 Million USD | -18113.31% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -10281.379% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -498.377% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -4443.128% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -17046.277% |
| Exelixis, Inc. | 1.58 Billion USD | 4.572% |
| Better Therapeutics, Inc. | 38.26 Million USD | -3857.524% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -552.544% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -77.061% |
| NLS Pharmaceutics AG | 11.8 Million USD | -12724.764% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -18729.218% |
| Gritstone bio, Inc. | 148.37 Million USD | -920.548% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -2098.963% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -9155.549% |
| Avid Bioservices, Inc. | 25.99 Million USD | -5724.85% |
| Insmed Incorporated | 949.26 Million USD | -59.517% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -9551.042% |
| MediWound Ltd. | 18.86 Million USD | -7925.376% |
| OmniAb, Inc. | 83.89 Million USD | -1704.909% |
| Alector, Inc. | 248.8 Million USD | -508.608% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -546.255% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -2797.989% |
| Zai Lab Limited | 547.47 Million USD | -176.583% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -279.835% |
| Aura Biosciences, Inc. | 84.99 Million USD | -1681.633% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -512.705% |
| Immunic, Inc. | 99.22 Million USD | -1426.086% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -852.273% |
| Veracyte, Inc. | 357.93 Million USD | -323.048% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 83.205% |
| FibroGen, Inc. | 398.11 Million USD | -280.351% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -10556.073% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -21883.735% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -21150.14% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -5752.541% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -378.364% |
| Galecto, Inc. | 35.62 Million USD | -4150.226% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -3621.468% |
| Fortrea Holdings Inc. | 457.3 Million USD | -231.124% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -2689.764% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -5143.535% |
| XBiotech Inc. | 37.51 Million USD | -3936.865% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -2098.963% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -7233.178% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -965.9% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -1428.365% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -1267.669% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -58.02% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -5149.534% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -251.623% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -6687.73% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -1265.806% |
| NexImmune, Inc. | 28.16 Million USD | -5275.796% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -27277.368% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -8362.915% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 46.214% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -5847.712% |
| Ainos, Inc. | 12.95 Million USD | -11590.476% |
| Pluri Inc. | 22.48 Million USD | -6635.89% |
| Prothena Corporation plc | 282.4 Million USD | -436.188% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -657.031% |
| Celularity Inc. | 215.05 Million USD | -604.102% |
| Rallybio Corporation | 78.93 Million USD | -1818.396% |
| Cue Biopharma, Inc. | 19.54 Million USD | -7648.583% |
| MeiraGTx Holdings plc | 151.07 Million USD | -902.282% |
| Omeros Corporation | 94.75 Million USD | -1498.113% |
| Humacyte, Inc. | 23.49 Million USD | -6344.346% |
| Immunocore Holdings plc | 308.04 Million USD | -391.569% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -44567.493% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -1643.197% |
| Blueprint Medicines Corporation | 722.86 Million USD | -109.477% |
| CalciMedica, Inc. | 21.81 Million USD | -6840.588% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -1928.165% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -783.988% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -413.402% |
| Pulmatrix, Inc. | 22.03 Million USD | -6770.986% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -4279.546% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -1603.945% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -174.533% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -1987.122% |
| Cytokinetics, Incorporated | 173.61 Million USD | -772.191% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -4299.396% |
| Nutriband Inc. | 5.73 Million USD | -26307.74% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -3371.965% |
| Vor Biopharma Inc. | 126.03 Million USD | -1101.425% |
| Roivant Sciences Ltd. | 1.18 Billion USD | -27.334% |
| Evogene Ltd. | 27.79 Million USD | -5348.823% |
| ProKidney Corp. | 151.52 Million USD | -899.345% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -1941.426% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -146.526% |
| CorMedix Inc. | 48.95 Million USD | -2992.926% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -904.796% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -3877.275% |
| Atai Life Sciences N.V. | 125.78 Million USD | -1103.822% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -1754.778% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -1760.025% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -499.571% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -4525.009% |
| MediciNova, Inc. | 10.9 Million USD | -13791.662% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -1075.46% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -20758.503% |
| GeoVax Labs, Inc. | 6.02 Million USD | -25044.213% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -217.875% |
| Biomea Fusion, Inc. | 126.13 Million USD | -1100.482% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | -15.428% |
| Mereo BioPharma Group plc | 35.84 Million USD | -4124.731% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -692.42% |
| Absci Corporation | 73.66 Million USD | -1955.532% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -5389.914% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -1033.489% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -525.295% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -477.844% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -628.015% |
| Allakos Inc. | 196.05 Million USD | -672.345% |
| Imunon, Inc. | 20.31 Million USD | -7355.423% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -1234.486% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -310.792% |
| BioAtla, Inc. | 129.68 Million USD | -1067.602% |
| NLS Pharmaceutics AG | 11.8 Million USD | -12724.764% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -9457.71% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -1683.165% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -3526.199% |
| XOMA Corporation | 46.46 Million USD | -3158.997% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -1262.071% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -962.892% |
| aTyr Pharma, Inc. | 12.97 Million USD | -11566.754% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -1360.82% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -775.935% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -494.365% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -3947.872% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -18310.483% |
| Akari Therapeutics, Plc | 16.8 Million USD | -8910.044% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -66489.621% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -405.893% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -22403.92% |
| UroGen Pharma Ltd. | 138.88 Million USD | -990.251% |
| Sutro Biopharma, Inc. | 243 Million USD | -523.116% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -20715.212% |
| Orgenesis Inc. | 45.75 Million USD | -3209.282% |
| Entera Bio Ltd. | 8.86 Million USD | -16990.609% |
| GH Research PLC | 41.22 Million USD | -3573.349% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -5790.104% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -1723.207% |
| Xencor, Inc. | 306.97 Million USD | -393.271% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -30592.114% |
| Replimune Group, Inc. | 234.77 Million USD | -544.975% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -7290.123% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -689.499% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -22403.92% |
| Portage Biotech Inc. | 18.19 Million USD | -8220.391% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -20758.503% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -1342.658% |
| OncoCyte Corporation | 25.63 Million USD | -5806.417% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -24741.3% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -13116.548% |
| Purple Biotech Ltd. | -22.46 Million USD | 6839.787% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -9088.277% |
| scPharmaceuticals Inc. | 65.17 Million USD | -2223.219% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -17814.058% |
| HilleVax, Inc. | 133.34 Million USD | -1035.572% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -14622.684% |
| Tharimmune, Inc. | 9.45 Million USD | -15914.73% |
| Genprex, Inc. | 31.06 Million USD | -4775.082% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -707.476% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -4725.917% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -197838.301% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -27699.716% |
| OKYO Pharma Limited | 8243.57 USD | -18368495.16% |
| Savara Inc. | 15.74 Million USD | -9517.199% |
| Curis, Inc. | 58.35 Million USD | -2494.856% |
| Daré Bioscience, Inc. | 33.6 Million USD | -4405.37% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -29634.542% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -5503.686% |
| BeiGene, Ltd. | 3.28 Billion USD | 53.927% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -7494.188% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -203.595% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -885.492% |
| Erasca, Inc. | 141.52 Million USD | -969.937% |
| bluebird bio, Inc. | 240.23 Million USD | -530.319% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -33349.01% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 13.288% |
| DBV Technologies S.A. | 92.16 Million USD | -1543.043% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -33349.01% |
| Moderna, Inc. | 6.39 Billion USD | 76.318% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -3453.775% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -10440.359% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -2170.173% |
| Travere Therapeutics, Inc. | 472 Million USD | -220.81% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -956.603% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -2339.077% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -3387.879% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -627.54% |
| MacroGenics, Inc. | 217.21 Million USD | -597.11% |
| RenovoRx, Inc. | 11.39 Million USD | -13187.364% |
| Adicet Bio, Inc. | 152.03 Million USD | -895.954% |
| Prime Medicine, Inc. | 186.63 Million USD | -711.314% |
| Aditxt, Inc. | 25.95 Million USD | -5735.003% |
| Adagene Inc. | 41.83 Million USD | -3519.84% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -20614.196% |
| Quantum-Si incorporated | 111.65 Million USD | -1256.118% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -781.134% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -10287.242% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -4127.089% |
| SciSparc Ltd. | 9.01 Million USD | -16704.217% |
| Vericel Corporation | 142.04 Million USD | -966.057% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -17392.05% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -6458.338% |
| Generation Bio Co. | 144.46 Million USD | -948.148% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -1723.712% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -1651.362% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -412.048% |
| Invivyd, Inc. | 205.75 Million USD | -635.937% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -1998.46% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -16045.731% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -1912.156% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -14619.821% |
| 2seventy bio, Inc. | 289.88 Million USD | -422.351% |
| Clene Inc. | 41.07 Million USD | -3586.675% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -11722.622% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -2663.391% |
| GeoVax Labs, Inc. | 6.02 Million USD | -25044.213% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -330.12% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -4022.365% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -4389.528% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -1360.172% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -4546.439% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -789.268% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -97.237% |
| Evaxion Biotech A/S | 22.27 Million USD | -6699.407% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -1017.149% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -544.676% |
| Trevena, Inc. | 38.41 Million USD | -3841.968% |
| Surrozen, Inc. | 18.55 Million USD | -8062.954% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -1794.087% |
| Cingulate Inc. | 22.75 Million USD | -6553.26% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 20311.265% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -3290.037% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -18290.076% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -1376.46% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -100.803% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -2339.392% |
| Clearmind Medicine Inc. | 8.74 Million USD | -17222.587% |
| Kronos Bio, Inc. | 128.11 Million USD | -1081.901% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -1701.109% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -51527.54% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -1401.808% |
| Statera Biopharma, Inc. | 28.82 Million USD | -5152.355% |
| ImmunityBio, Inc. | 362.87 Million USD | -317.29% |
| Korro Bio, Inc. | 84.53 Million USD | -1691.265% |
| Kineta, Inc. | 21.15 Million USD | -7057.44% |
| BioVie Inc. | 31.95 Million USD | -4639.337% |
| Codexis, Inc. | 66.51 Million USD | -2176.418% |
| Celularity Inc. | 215.05 Million USD | -604.102% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -568.176% |
| Celcuity Inc. | 66.23 Million USD | -2186.306% |
| Virax Biolabs Group Limited | 6.54 Million USD | -23028.355% |
| Cibus, Inc. | 320.3 Million USD | -372.746% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -3421.46% |
| IN8bio, Inc. | 30.33 Million USD | -4891.357% |
| Kodiak Sciences Inc. | 277.32 Million USD | -446.02% |
| Annexon, Inc. | 143.72 Million USD | -953.574% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -1086.783% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -6509.752% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -236498.125% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -94.235% |
| Eyenovia, Inc. | 25.4 Million USD | -5860.015% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -979.163% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -27124.524% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -1813.523% |
| Arcellx, Inc. | 200.19 Million USD | -656.361% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -3198.972% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -599.7% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -15107.673% |
| Moolec Science SA | 52.75 Million USD | -2770.541% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -2376.738% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -3153.606% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -1509.648% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -16133.381% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -6591.676% |
| Humacyte, Inc. | 23.49 Million USD | -6344.346% |
| 89bio, Inc. | 151.2 Million USD | -901.447% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -1789.667% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -10314.223% |
| Genelux Corporation | 24.33 Million USD | -6122.429% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -4363.721% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -775.94% |
| Notable Labs, Ltd. | 14.77 Million USD | -10152.051% |
| Liquidia Corporation | 87.98 Million USD | -1621.027% |
| Mustang Bio, Inc. | 48.5 Million USD | -3022.055% |
| Immunovant, Inc. | 282.7 Million USD | -435.614% |
| Quantum-Si incorporated | 111.65 Million USD | -1256.118% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -6616.767% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -7020.083% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -1384.363% |
| Acasti Pharma Inc. | 11.3 Million USD | -13299.062% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -6506.261% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -9376.149% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -3153.466% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -133361.545% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -9431.839% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -5093.36% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -3558.97% |
| PepGen Inc. | 84.76 Million USD | -1686.362% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -5010.283% |
| United Therapeutics Corporation | 885.1 Million USD | -71.08% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -6513.216% |
| Solid Biosciences Inc. | 104.31 Million USD | -1351.592% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -4527.054% |
| Immuneering Corporation | 58.41 Million USD | -2492.284% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -29647.697% |
| Silo Pharma, Inc. | 3.92 Million USD | -38509.985% |
| Belite Bio, Inc | 31.66 Million USD | -4681.571% |
| XOMA Corporation | 46.46 Million USD | -3158.997% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -2141.64% |
| Bionomics Limited | 17.89 Billion USD | 91.537% |
| Apogee Therapeutics, Inc. | 93 Million USD | -1528.15% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 4343.913% |
| uniQure N.V. | 285.08 Million USD | -431.148% |
| Cassava Sciences, Inc. | 105.95 Million USD | -1329.097% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -20614.196% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -679.698% |
| Forte Biosciences, Inc. | 32.47 Million USD | -4562.463% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -18124.487% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -5051.311% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -27124.524% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -10556.073% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -16934.852% |
| Altimmune, Inc. | 30.55 Million USD | -4855.583% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -254.08% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 4343.913% |
| Compugen Ltd. | 43.97 Million USD | -3343.697% |
| Peak Bio, Inc. | 1249.13 USD | -121222510.937% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -1942.941% |
| Benitec Biopharma Inc. | 22.38 Million USD | -6665.383% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -522.655% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -5205.077% |
| Zura Bio Limited | 62.63 Million USD | -2317.427% |
| PolyPid Ltd. | 21.04 Million USD | -7095.191% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -9203.441% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -5205.077% |
| Instil Bio, Inc. | 85.78 Million USD | -1665.143% |
| argenx SE | 1.53 Billion USD | 1.259% |
| Immunome, Inc. | 122.82 Million USD | -1132.884% |
| Verona Pharma plc | 67.15 Million USD | -2154.95% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -5749.828% |
| Shattuck Labs, Inc. | 93.61 Million USD | -1517.523% |
| CervoMed Inc. | 14.95 Million USD | -10023.356% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -2041.674% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -17622.706% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -2869.075% |
| Moolec Science SA | 52.75 Million USD | -2770.541% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -9105.906% |
| Design Therapeutics, Inc. | 78.19 Million USD | -1836.601% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -1639.672% |
| NeurAxis, Inc. | 8.82 Million USD | -17065.784% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -11932.006% |
| Lumos Pharma, Inc. | 38.66 Million USD | -3816.276% |
| Achilles Therapeutics plc | 75.25 Million USD | -1912.129% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -5749.828% |
| 180 Life Sciences Corp. | 13.47 Million USD | -11135.229% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -5613.541% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -51527.54% |
| Nutriband Inc. | 5.73 Million USD | -26307.74% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -1266.878% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -2620.838% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -2876.136% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -2190.849% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -2697.748% |
| Palisade Bio, Inc. | 13.32 Million USD | -11268.078% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -3234.643% |
| Beam Therapeutics Inc. | 554.19 Million USD | -173.231% |
| Neurogene Inc. | 55.58 Million USD | -2624.265% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -509.374% |
| AEON Biopharma, Inc. | 48.42 Million USD | -3026.697% |
| Sesen Bio, Inc. | 78.38 Million USD | -1831.881% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -1712.817% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -11930.194% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -235.754% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -1622.867% |
| Athira Pharma, Inc. | 125.46 Million USD | -1106.883% |
| Vaccinex, Inc. | 23.45 Million USD | -6355.886% |
| HCW Biologics Inc. | 21.02 Million USD | -7101.173% |
| XOMA Corporation | 46.46 Million USD | -3158.997% |
| Nektar Therapeutics | 190.9 Million USD | -693.192% |
| Arvinas, Inc. | 480 Million USD | -215.464% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -66489.621% |
| Merus N.V. | 200.49 Million USD | -655.249% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -1365.075% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -4273.853% |
| Rezolute, Inc. | 70.38 Million USD | -2051.289% |
| Clene Inc. | 41.07 Million USD | -3586.675% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -9145.232% |
| BeyondSpring Inc. | 24.86 Million USD | -5989.797% |
| Synlogic, Inc. | 58.53 Million USD | -2487.009% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -8363.157% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -33609.439% |
| Peak Bio, Inc. | 1249.13 USD | -121222510.937% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -2405.092% |
| Krystal Biotech, Inc. | 160.42 Million USD | -843.879% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -459.518% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -335.075% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -70109.307% |
| MannKind Corporation | 125.59 Million USD | -1105.624% |
| Ikena Oncology, Inc. | 84.57 Million USD | -1690.354% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -15596.362% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -1589.968% |
| Gossamer Bio, Inc. | 183.75 Million USD | -724.029% |
| CohBar, Inc. | 12.38 Million USD | -12123.052% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -2885.23% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -5389.914% |
| Legend Biotech Corporation | 583.14 Million USD | -159.666% |
| Mural Oncology plc | 192.07 Million USD | -688.369% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -2155.094% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -9278.771% |
| Disc Medicine, Inc. | 91.12 Million USD | -1561.704% |
| Champions Oncology, Inc. | 28.11 Million USD | -5286.795% |
| REGENXBIO Inc. | 321.15 Million USD | -371.492% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -28144.02% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -2615.812% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -3786.558% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -1224.124% |
| Vaxart, Inc. | 90.72 Million USD | -1569.012% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -17672.612% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -3438.405% |
| Cellectis S.A. | 97.32 Million USD | -1455.927% |
| Longeveron Inc. | 21.25 Million USD | -7025.779% |
| Repare Therapeutics Inc. | 167.35 Million USD | -804.789% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | -11.273% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -1901.756% |
| Revolution Medicines, Inc. | 498.76 Million USD | -203.595% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -22663.5% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -3345.029% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -1930.068% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -2074.521% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -13591.031% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 68.288% |
| Denali Therapeutics Inc. | 527.23 Million USD | -187.204% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -17392.05% |
| Veru Inc. | 101.34 Million USD | -1394.086% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -6369.125% |
| Cingulate Inc. | 22.75 Million USD | -6553.26% |
| Passage Bio, Inc. | 108.38 Million USD | -1297.031% |
| Context Therapeutics Inc. | 25.07 Million USD | -5939.37% |
| Exicure, Inc. | 14.07 Million USD | -10657.516% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -634.834% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -3396.982% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -16399.729% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -499.735% |
| Nuvalent, Inc. | 149.49 Million USD | -912.916% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -18670.874% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -1360.905% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -6959.667% |
| OmniAb, Inc. | 83.89 Million USD | -1704.909% |
| Anew Medical, Inc. | 1.3 Million USD | -116303.773% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -4521.621% |
| Lipocine Inc. | 15.08 Million USD | -9941.207% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -2110.132% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -1888.428% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -3656.056% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -1218.52% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -6664.778% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -127.997% |
| Ocugen, Inc. | 71.56 Million USD | -2015.819% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -1513.18% |
| Q32 Bio Inc. | 92.68 Million USD | -1533.824% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -7051.355% |
| Alumis Inc. Common Stock | 158.17 Million USD | -857.318% |
| Equillium, Inc. | 50.6 Million USD | -2892.191% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -2326.414% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -10789.375% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -7926.607% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -3125.124% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -1296.039% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -12118.683% |
| Dominari Holdings Inc. | 23.83 Million USD | -6252.96% |
| Edesa Biotech, Inc. | 9.22 Million USD | -16318.386% |
| vTv Therapeutics Inc. | 11.9 Million USD | -12617.124% |
| Bio-Techne Corporation | 563.03 Million USD | -168.938% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -270.403% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -463.421% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -1044.74% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -10407.446% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -825.024% |
| Nkarta, Inc. | 131.65 Million USD | -1050.192% |
| BioCardia, Inc. | 12.12 Million USD | -12392.6% |
| Iterum Therapeutics plc | 47.46 Million USD | -3089.997% |